The most common materials in CNC medical parts manufacturing include austenitic stainless steels such as 316L stainless steel, other approved stainless grades, and titanium alloys; aluminum and engineering plastics also serve selected non-implant device parts. The correct choice depends on the released material specification, device function, patient or fluid contact, cleaning or sterilization exposure, corrosion, strength, weight, surface, and traceability requirements. Buyers should provide the exact grade, standard, condition, product form, and substitution authority in the RFQ.
Material family names are not acceptance specifications. “Medical stainless” can refer to grades with different corrosion, hardness, heat-treatment, magnetic, and machining behavior, while “titanium” can refer to commercially pure grades or alloys with different approved uses. Stainless steel CNC machining and titanium machining must therefore follow the device drawing and risk controls. Biological suitability is evaluated for the applicable contact and final device state; it is not created by a material label alone.
316L stainless steel is widely specified for instruments, fittings, housings, shafts, and device components that need austenitic stainless corrosion resistance and a finish compatible with the approved cleaning or passivation route. The “L” denotes lower carbon content, which helps limit sensitization risk in relevant thermal or welding conditions. It does not guarantee cleanliness, passivation quality, or suitability for every contact environment.
The buyer should define the governing material standard, composition or property evidence, solution condition where applicable, stock form, surface treatment, and traceability. Chloride exposure, crevices, dissimilar-metal contact, residual iron, heat tint, and an unsuitable finish can still undermine corrosion performance. Final acceptance should consider the manufactured and processed surface, not only the raw-stock certificate.
Material Route | Use When the Approved Design Needs | RFQ and Validation Boundary |
|---|---|---|
Austenitic corrosion resistance, non-heat-treated toughness, and compatible cleaning or passivation | State standard, condition, contact environment, finish, passivation, certificate, and final corrosion-related requirements | |
General Stainless Steel | Grade-specific hardness, wear, strength, magnetic, corrosion, or instrument behavior | Do not substitute grades; define heat treatment, hardness, surface route, and corrosion conditions |
Approved low-density, corrosion, strength, imaging, or patient-contact performance | Identify alloy or CP grade, condition, contact, surface, contamination controls, and biological-evaluation responsibility |
Beyond 316L, stainless steel grades can be selected for instrument hardness, spring behavior, wear resistance, strength, magnetic response, or cost. Precipitation-hardening stainless such as 17-4PH may suit approved structural or device components needing higher strength, while martensitic grades may serve cutting or gripping features after controlled heat treatment. These are design decisions, not interchangeable “medical steel” options.
Heat treatment can change hardness, size, distortion, corrosion behavior, and finishing sequence. The RFQ should identify condition and hardness at delivery, machining allowance, special-process source requirements, passivation or polishing, and final inspection state. A supplier cannot price or validate the route accurately when only the alloy family is provided.
Titanium alloys and commercially pure titanium are used where an approved design needs low density, corrosion resistance, specific strength, or patient-contact performance. Exact grade and condition matter. Commercially pure titanium and Ti-6Al-4V are not equivalent in strength, composition, machining, or device application.
Titanium machining concentrates heat near the tool, and tool wear or surface damage can affect dimensions and finish. The process plan should address tool condition, stable workholding, burr control, contamination, and delivered surface. For patient-contact applications, the legal manufacturer remains responsible for biological evaluation under the applicable device plan, including manufacturing residues and final processing.
Ti-6Al-4V ELI (Grade 23) is an extra-low-interstitial variant used in approved medical and aerospace applications where its specified chemistry and properties are required. It should not be selected merely because the part is described as medical or high-end. The drawing must identify the applicable material standard, condition, product form, and evidence.
Grade 23 does not remove the need to evaluate contact, fatigue, surface, cleanliness, sterilization, and complete device risk. Nor does it authorize substitution for another titanium grade. Buyers should compare the intended function and approved material data before accepting added material cost and machining exposure.
Selection Question | Likely Material Direction | Confirmation Before Release |
|---|---|---|
Does the approved part need austenitic corrosion behavior and compatible reusable processing? | Contact environment, standard, condition, finish, passivation, cleaning, and corrosion acceptance | |
Does function require grade-specific hardness, strength, wear, or magnetic response? | Exact grade, heat treatment, hardness, distortion allowance, surface route, and certificate scope | |
Does the approved design require titanium-specific density, corrosion, strength, or contact behavior? | Exact grade, condition, product form, contact, surface, residues, traceability, and validation ownership |
Cleaning chemistry, temperature, sterilization cycles, body or process fluids, galvanic couples, wear, and crevice geometry can change material performance. Corrosion resistance measured for bulk material does not prove that a machined, heat-tinted, scratched, contaminated, coated, or poorly passivated surface will perform identically. The device plan should define relevant final-state verification.
ISO 10993 biological evaluation is risk-based and tied to applicable patient contact and the final device state. A certificate for 316L or titanium does not establish biological safety for residues, lubricants, finishing compounds, packaging, or degradation products. Buyers should state material and surface evidence while keeping device-level evaluation with the responsible manufacturer.
Titanium can reduce weight and meet approved corrosion or contact needs, but it increases stock and machining exposure. For many non-implant housings, fixtures, instrument parts, and support hardware, an approved stainless grade, aluminum alloy, or engineering plastic may be more appropriate. Aluminum and plastics require their own chemical, thermal, wear, cleaning, and dimensional review.
Compare candidates against explicit design requirements rather than prestige. Record which criterion eliminates each option and what verification remains. This creates a defensible material decision and prevents the supplier from substituting a cheaper or easier grade based only on similar appearance or general properties.
Material choice changes stock availability, minimum buys, tool wear, setup strategy, burr control, heat treatment, passivation, polishing, cleaning, inspection, and scrap exposure. The quotation should separate raw material, certificates, special processes, nonrecurring work, and recurring unit cost. A low unit price is misleading when the required final-state processing or evidence is excluded.
Send part and revision, material standard, grade, condition, product form, contact category, loads, cleaning or sterilization environment, critical surfaces, special processes, certificate and traceability needs, and substitution authority. The supplier should return exceptions and schedule assumptions before material purchase.
The most common choices include 316L stainless steel, other approved stainless steel grades, and titanium, with aluminum and engineering plastics used where the device design permits. They are common because grade-specific combinations of corrosion, strength, weight, surface processing, and manufacturability can suit medical equipment and instruments. None is universally best or automatically biocompatible.
For a medical device RFQ, specify exact material and final condition, then connect contact, environment, surface, cleaning, evidence, and change control to the approved part. That gives engineering and procurement a verifiable basis for choosing material without paying for unsupported performance or accepting an unapproved substitution.